Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins-Reference-Cited by-同舟云学术

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Published:2002-01 Issue:1 Volume:8 Page:27-34
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Reynolds Louise E.,Wyder Lorenza,Lively Julie C.,Taverna Daniela,Robinson Stephen D.,Huang Xiaozhu,Sheppard Dean,Hynes Richard O.,Hodivala-Dilke Kairbaan M.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0102-27.pdf

Reference45 articles.

1. Ferrara, N. & Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 5, 1359–1364 (1999).

2. Hynes, R.O., Bader, B.L. & Hodivala-Dilke, K. Integrins in vascular development. Braz. J. Med. Biol. Res. 32, 501–510 (1999).

3. Carmeliet, P. & Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).

4. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439 (1996).

5. Shalaby, F. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66 (1995).

Cited by 564 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating integrins with the hallmarks of cancer;Matrix Biology;2024-06

2. The heparin-binding domain of VEGF165 directly binds to integrin αvβ3 and VEGFR2/KDR D1: a potential mechanism of negative regulation of VEGF165 signaling by αvβ3;Frontiers in Cell and Developmental Biology;2024-05-09

3. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy;International Journal of Molecular Sciences;2024-01-11

4. Atherosclerosis is the outcome of adaptive complexity in the Arterial Endothelial Microenvironment;Metabolic Syndrome;2024

5. Advances in SEMA3F regulation of clinically high-incidence cancers;Cancer Biomarkers;2023-10-13